Mostrar registro simples

dc.contributor.authorAlencastro, Paulo Ricardo dept_BR
dc.contributor.authorWolff, Fernando Herzpt_BR
dc.contributor.authorOliveira, Renato Rodrigues dept_BR
dc.contributor.authorIkeda, Maria Letícia Rodriguespt_BR
dc.contributor.authorBarcellos, Nêmora Tregnagopt_BR
dc.contributor.authorBrandao, Ajacio Bandeira de Mellopt_BR
dc.contributor.authorFuchs, Sandra Cristina Pereira Costapt_BR
dc.date.accessioned2014-11-11T02:14:21Zpt_BR
dc.date.issued2012pt_BR
dc.identifier.issn1742-6405pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/106616pt_BR
dc.description.abstractBackground: Metabolic Syndrome (MetS) is based on the same individual components, but has received several amendments to the original definition. In this study, we verified the prevalence of metabolic syndrome according to different criteria, and the impact of each component on the diagnostic. Methods: This cross-sectional study enrolled HIV infected patients from a HIV/AIDS reference Center in southern Brazil. Metabolic syndrome was identified according to the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP-ATPIII), the International Diabetes Federation (IDF) and the American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI) criteria, and using a standardized questionnaire and blood testing. Results: A sample of 1240, out of 1295, HIV-infected patients was enrolled. Males were on average older, more educated, and had shorter time since the HIV diagnosis. The population attributable risk (PAR) for waist circumference explained 80% of the prevalence among men and women (AHA/NHLBI criteria). Triglycerides had the highest impact on prevalence of metabolic syndrome according to all criteria, independently of age, skin color and HAART use, among men. Conclusions: In this large sample of HIV infected patients, the overall prevalence of metabolic syndrome, under either classification, was noticeable and the AHA/NHLBI definition accounted for the highest prevalence.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofAIDS research and therapy. [London]. Vol. 29, no. 2 (2012), 7 p.pt_BR
dc.rightsOpen Accessen
dc.subjectMetabolic syndromeen
dc.subjectSíndrome metabólicapt_BR
dc.subjectPopulation attributable risken
dc.subjectSíndrome da imunodeficiência adquiridapt_BR
dc.subjectCircunferência da cinturapt_BR
dc.subjectHIV/AIDSen
dc.subjectNCEP-ATPIIIen
dc.subjectIDFen
dc.subjectAHA/NHLBIen
dc.subjectWaist circumferenceen
dc.titleMetabolic syndrome and population attributable risk among HIV/AIDS patients: comparison between NCEP-ATPIII, IDF and AHA/NHLBI definitionspt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000937192pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples